Dupilumab modulates type II IL-4/IL-13 receptor-expressing immune cells in eosinophilic chronic rhinosinusitis

Journal of Allergy and Clinical Immunology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles